Hitoshi Kiyoi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Transcription Factor

Top Venues

Scientific reports

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Yoko Ushijima, Seara Naruse, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, Marie Nakashima, Jeong Hui Kim, Seitaro Terakura, Rika Kihara, Koichi Watamoto, Takahiro Nishiyama, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi
Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific reports 14 (1) (2024)
Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta, Mio Kurata, Yosuke Minami, Naoto Takahashi, Chiaki Nakaseko, Noriyoshi Iriyama, Katsumichi Fujimaki, Kazuhiko Kakihana, Yoji Ogasawara, Takaaki Ono, Masaya Okada, Tetsuzo Tauchi, Toshihiro Miyamoto, Kazunori Ohnishi, Emiko Sakaida, Shin Fujisawa, Yukio Kobayashi, Norio Asou, Tomoki Naoe, Hitoshi Kiyoi, Yasushi Miyazaki
Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chronic Myeloid Leukemia: the Randomized JALSG CML212 Study. Blood advances (2024)
Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. Oncogene 43 (6) (2023)
Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. Oncogene 43 (6) (2023)
Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. Oncogene 43 (6) (2023)
Kanae Imai, Yuki Takeuchi, Seitaro Terakura, Shingo Okuno, Yoshitaka Adachi, Masahide Osaki, Koji Umemura, Ryo Hanajiri, Kazuyuki Shimada, Makoto Murata, Hitoshi Kiyoi
Dual CAR-T cells targeting CD19 and CD37 are effective in target antigen loss B cell tumor models. Molecular cancer therapeutics (2023)
Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. Oncogene (2023)
Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia. Oncogene 43 (6) (2023)
Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim, Yoko Ushijima, Akimi Akashi, Yohei Yamaguchi, Hikaru Hattori, Marie Nakashima, Seara Ikeno, Rika Kihara, Takahiro Nishiyama, Takanobu Morishita, Koichi Watamoto, Yukiyasu Ozawa, Kunio Kitamura, Hitoshi Kiyoi
Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells. Nature communications 13 (1) (2022)
Koya Odaira, Takahiko Yasuda, Kentaro Okada, Takuya Shimooka, Yukino Kojima, Mina Noura, Shogo Tamura, Shingo Kurahashi, Eisuke Iwamoto, Masashi Sanada, Itaru Matsumura, Yasushi Miyazaki, Tetsuhito Kojima, Hitoshi Kiyoi, Shinobu Tsuzuki, Fumihiko Hayakawa
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene. Cancer science (2022)
Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu Tsuzuki, Hiroo Ueno, Eisuke Iwamoto, Yuka Iijima-Yamashita, Tomomi Yamada, Takashi Kanamori, Rieko Nishimura, Yachiyo Kuwatsuka, Satoru Takada, Masatsugu Tanaka, Shuichi Ota, Nobuaki Dobashi, Etsuko Yamazaki, Asao Hirose, Tohru Murayama, Masahiko Sumi, Shinya Sato, Naoyuki Tange, Yukinori Nakamura, Yuna Katsuoka, Emiko Sakaida, Toyotaka Kawamata, Hiroatsu Iida, Yuichi Shiraishi, Yasuhito Nannya, Seishi Ogawa, Masafumi Taniwaki, Norio Asou, Yoshihiro Hatta, Hitoshi Kiyoi, Itaru Matsumura, Keizo Horibe, Hiroyuki Mano, Tomoki Naoe, Yasushi Miyazaki, Fumihiko Hayakawa
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations. Blood (2021)
Kazuyuki Shimada, Hitoshi Kiyoi
Current progress and future perspectives of research on intravascular large B-cell lymphoma. Cancer science 112 (10) (2021)
Shingo Okuno, Yoshitaka Adachi, Seitaro Terakura, Jakrawadee Julamanee, Toshiyasu Sakai, Koji Umemura, Kotaro Miyao, Tatsunori Goto, Atsushi Murase, Kazuyuki Shimada, Tetsuya Nishida, Makoto Murata, Hitoshi Kiyoi
Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T Cells. Journal of immunology (Baltimore, Md. : 1950) (2021)
Shunsuke Kunou, Kazuyuki Shimada, Mika Takai, Akihiko Sakamoto, Tomohiro Aoki, Tomoya Hikita, Yusuke Kagaya, Eisuke Iwamoto, Masashi Sanada, Satoko Shimada, Fumihiko Hayakawa, Chitose Oneyama, Hitoshi Kiyoi
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma. Oncogene 40 (23) (2021)
Hitoshi Kiyoi, Joan D Morris, Iekuni Oh, Yoshinobu Maeda, Hironobu Minami, Toshihiro Miyamoto, Toru Sakura, Hiroatsu Iida, Catherine A Tuglus, Yuqi Chen, Cedric Dos Santos, James Kalabus, Abraham Anderson, Tomoko Hata, Yasuhiro Nakashima, Yukio Kobayashi
Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia. Cancer science 111 (4) (2020)
Naomi Kawashima, Yuichi Ishikawa, Yoshiko Atsuta, Masashi Sawa, Yukiyasu Ozawa, Masaki Hayashi, Akio Kohno, Akihiro Tomita, Tomoya Maeda, Emiko Sakaida, Kensuke Usuki, Maki Hagihara, Heiwa Kanamori, Hiroshi Matsuoka, Miki Kobayashi, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi, null null
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study. Cancer science 111 (7) (2020)
Takahiko Yasuda, Masashi Sanada, Dai Nishijima, Takashi Kanamori, Yuka Iijima, Hiroyoshi Hattori, Akiko Saito, Hiroaki Miyoshi, Yuichi Ishikawa, Norio Asou, Kensuke Usuki, Shinsuke Hirabayashi, Motohiro Kato, Masaki Ri, Hiroshi Handa, Tadao Ishida, Hirohiko Shibayama, Masahiro Abe, Chisako Iriyama, Kennosuke Karube, Momoko Nishikori, Koichi Ohshima, Keisuke Kataoka, Kenichi Yoshida, Yuichi Shiraishi, Hiroaki Goto, Souichi Adachi, Ryoji Kobayashi, Hitoshi Kiyoi, Yasushi Miyazaki, Seishi Ogawa, Hiroki Kurahashi, Hisayuki Yokoyama, Atsushi Manabe, Shinsuke Iida, Akihiro Tomita, Keizo Horibe
Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. Cancer science 111 (9) (2020)
Hitoshi Kiyoi, Naomi Kawashima, Yuichi Ishikawa
FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development. Cancer science 111 (2) (2019)
Naomi Kawashima, Akimi Akashi, Yasunobu Nagata, Rika Kihara, Yuichi Ishikawa, Norio Asou, Shigeki Ohtake, Shuichi Miyawaki, Toru Sakura, Yukiyasu Ozawa, Noriko Usui, Heiwa Kanamori, Yoshikazu Ito, Kiyotoshi Imai, Youko Suehiro, Kunio Kitamura, Emiko Sakaida, Akihiro Takeshita, Hitoshi Suzushima, Tomoki Naoe, Itaru Matsumura, Yasushi Miyazaki, Seishi Ogawa, Hitoshi Kiyoi, null null
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study. Annals of hematology 98 (1) (2018)